Publications by authors named "M Alessi"

Germline variants of FLI1, essential for megakaryopoiesis, are linked to bleeding disorders, platelet aggregation defects and mild thrombocytopenia. However, the mechanisms behind these abnormalities remain unclear. This study aims to elucidate the impact of FLI1 variants on human megakaryocytes and platelets.

View Article and Find Full Text PDF

Background: Platelet transfusion is considered the standard treatment for preventing or controlling severe haemorrhage in Glanzmann thrombasthenia (GT). However, platelet transfusion can have detrimental effects, including the production of anti-GPIIb/IIIa isoantibodies or anti-HLA antibodies (Ab) and platelet transfusion refractoriness. Recombinant activated factor VII (rFVIIa) has been proposed as an alternative treatment to platelet transfusion.

View Article and Find Full Text PDF

Background: Inherited platelet diseases are bleeding disorders characterized by either defects in platelet count or platelet function, the latter being less common and very heterogeneous. Numerous gene variants associated with abnormal receptors, granules, and signaling pathways have been reported. Despite significant advancements in our understanding, many patients still lack a precise diagnosis.

View Article and Find Full Text PDF
Article Synopsis
  • Steal syndrome occurs when blood flow is redirected through collateral vessels due to an obstruction in an artery, which can lead to conditions like subclavian steal syndrome and double steal phenomenon.
  • A case study presented involves an elderly patient suffering from cerebrovascular issues who experienced neurological symptoms while chewing, linked to specific artery blockages discovered via angiography.
  • Successful treatment was achieved by performing endovascular revascularization on the affected arteries using a specialized stent, which resolved the patient’s symptoms.
View Article and Find Full Text PDF

Cognitive deficits, a diagnostic criterion for depressive disorders, may precede or follow the development of depressive symptoms and major depressive disorder. However, an individual can report an increase in depressive symptoms without any change in cognitive functioning. While ethnoracial minority group differences exist, little is known to date about how the relationship between depressive symptoms and cognitive function may differ by ethnoracial minority status.

View Article and Find Full Text PDF